HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

6th Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 28-30 | London, UK

September 28 -30, 2026 | London, UK

Autologous Organ Transplantation

Autologous Organ Transplantation

Autologous Organ Transplantation represents a ground-breaking approach in the field of transplant medicine, offering a potential solution to the longstanding challenges of organ rejection and donor shortages. Unlike traditional organ transplants, where organs are sourced from external donors, autologous transplantation involves transplanting tissues or organs that are derived from the patient's own body. This eliminates the risk of rejection by the recipient's immune system, as the transplanted tissue is genetically identical to the recipient's own cells. The process typically involves harvesting healthy tissue from the patient, often through biopsy or surgical excision, and then growing and/or modifying the tissue ex vivo before transplantation. This approach is particularly promising for regenerative medicine applications, where damaged or diseased tissues can be replaced with healthy autologous grafts, thereby promoting tissue repair and regeneration. Autologous transplantation is already being used in clinical settings for procedures such as autologous skin grafts for burn victims and autologous bone marrow transplants for patients with hematologic malignancies. In recent years, advances in stem cell biology and tissue engineering have expanded the possibilities for autologous transplantation, enabling the regeneration of complex tissues and organs such as cartilage, blood vessels, and even organs like the liver and kidneys. However, challenges remain in scaling up these techniques for widespread clinical use, including the need for efficient methods of tissue harvesting, processing, and transplantation, as well as the high cost and complexity of the procedures. Moreover, autologous transplantation may not be feasible for all patients, particularly those with certain genetic or medical conditions that preclude the use of their own tissues. Despite these challenges, autologous organ transplantation holds immense promise for improving patient outcomes and addressing the growing demand for donor organs. With continued research and technological innovation, autologous transplantation has the potential to revolutionize the field of transplant medicine and pave the way for personalized regenerative therapies tailored to individual patients' needs.

Committee Members
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Kunal Mitra

Kunal Mitra

Florida Tech, United States
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Ivan Kelnar

Ivan Kelnar

Institute of Macromolecular Chemistry, Czech Academy of Sciences, Czech Republic
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Lucie Bacakova

Lucie Bacakova

Institute of Physiology of the Czech Academy of Sciences, Czech Republic
TERMC 2026 Speakers
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Gokarneshan Narayanan

Gokarneshan Narayanan

SSM College of Engineering (Formerly), India
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Sandeep Shrivastava

Sandeep Shrivastava

Datta Meghe Institute of Medical Sciences, India
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Vasiliki E Kalodimou

Vasiliki E Kalodimou

European University-Cyprus Ltd, Cyprus
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Aradhana Kasimsetty

Aradhana Kasimsetty

National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States
Tags

Submit your abstract Today

Youtube
Watsapp